MarketResearchReprots.com has announced the addition of “Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027” research report to their website www.MarketResearchReports.com
Lewes, DE -- (SBWIRE) -- 08/09/2018 -- Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Attention Deficit Hyperactivity Disorder in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Attention Deficit Hyperactivity Disorder from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
- The United States
- EU5 (Germany, France, Italy, Spain and the United Kingdom)
Study Period: 2016-2027
Attention Deficit Hyperactivity Disorder - Disease Understanding and Treatment Algorithm
According to American Psychiatric Association, ADHD is a brain/neurodevelopmental/neurobehavioral disorder and is one of the most common mental disorders affecting children. The disease also affects many adults. Symptoms of ADHD include inattention (not being able to keep focus), hyperactivity (excess movement that is not fitting to the setting) and impulsivity (hasty acts that occur in the moment without thought).
The Publisher Attention Deficit Hyperactivity Disorder market report gives the thorough understanding of the Attention Deficit Hyperactivity Disorder by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Attention Deficit Hyperactivity Disorder in the US, Europe, and Japan.
Attention Deficit Hyperactivity Disorder Epidemiology
The Attention Deficit Hyperactivity Disorder epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Publisher report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented as Prevalent Cases, Age Specific Prevalence, and Diagnosed and Treatable population] scenario of Attention Deficit Hyperactivity Disorder in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to National Institute of Mental Health, the prevalence of children ever diagnosed with ADHD increased by 42% between 2003 (7.8%) and 2011 (11.0%). As per National Comorbidity Survey–Adolescent Supplement (NCS-A), the lifetime prevalence of ADHD among U.S. adolescents aged 13 to 18 years was found to be 8.7%.
Attention Deficit Hyperactivity Disorder Drug Chapters
This segment of the Attention Deficit Hyperactivity Disorder report encloses the detailed analysis of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
While there is no cure for ADHD, currently available treatments can help reduce symptoms and improve functioning. Treatments include medications, psychotherapy, education or training, or a combination of treatments. Stimulant medications commonly prescribed for attention deficit disorder include methylphenidate (Ritalin, Concerta, Metadate, Methylin) and certain amphetamines (Dexedrine, Adderall etc.). Other newer drugs approved for the treatment of attention deficit disorder include Strattera (atomoxetine, a selective norepinephrine reuptake inhibitor) and Vyvanse (lisdexamfetamine dimesylate).
Attention Deficit Hyperactivity Disorder Market Outlook
The Attention Deficit Hyperactivity Disorder market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
Many players such as Sunovion, Orient Pharma, Shire and many more are involved in developing therapies for Attention Deficit Hyperactivity Disorder. Launch of emerging therapies such as Dasotraline (Sunovion), ORADUR-Methylphenidate (Orient Pharma), SHP465 (Shire) etc. are expected to significantly change the treatment landscape in of ADHD in the upcoming years.
Attention Deficit Hyperactivity Disorder Drugs Uptake
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2016-2027. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Attention Deficit Hyperactivity Disorder Report Insights
- Patient Population
- Therapeutic Approaches
- Pipeline Analysis
- Market Size and Trends
- Market Opportunities
- Impact of upcoming Therapies
Attention Deficit Hyperactivity Disorder Report Key Strengths
- 10 Years Forecast
- 7MM Coverage
- Epidemiology Segmentation
- Sub-type Segmentation
- Key Cross Competition
- Highly Analyzed Market
- Drugs Uptake
Attention Deficit Hyperactivity Disorder Report Assessment
- Current Treatment Practices
- Unmet Needs
- Pipeline Product Profiles
- Market Attractiveness
- Market Drivers and Barriers
- This Publisher report will help to develop Business Strategies by understanding the trends shaping and driving Attention Deficit Hyperactivity Disorder market
- Organize sales and marketing efforts by identifying the best opportunities for Attention Deficit Hyperactivity Disorder market
- To understand the future market competition in the Attention Deficit Hyperactivity Disorder market.
Spanning over 120 pages "Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027" report covers Report Introduction, Attention Deficit Hyperactivity Disorder Market Overview at a Glance, Disease Background and Overview: Attention Deficit Hyperactivity Disorder, Epidemiology and Patient Population, Attention Deficit Hyperactivity Disorder: Country- Wise Epidemiology, Treatments & Medical Practices, Marketed drugs, Emerging Therapies, Attention Deficit Hyperactivity Disorder Market Size, 7MM Attention Deficit Hyperactivity Disorder: Country-Wise Market Analysis, Report Methodology.
Please visit this link for more details: https://www.marketresearchreports.com/delveinsight/attention-deficit-hyperactivity-disorder-adhd-market-insights-epidemiology-and-market
Find all Drug Pipeline Reports at: https://www.marketresearchreports.com/drug-pipeline
For related reports please visit: https://www.marketresearchreports.com/search/site/Attention%2520Deficit%2520Hyperactivity%2520Disorder
Read our Interactive Market Research Blog
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact